financetom
Business
financetom
/
Business
/
BRIEF-Terex Announces Expiration Of The Waiting Period Under The Hart-Scott-Rodino Act For Proposed Acquisition Of Environmental Solutions Group (Esg) From Dover Corporation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Terex Announces Expiration Of The Waiting Period Under The Hart-Scott-Rodino Act For Proposed Acquisition Of Environmental Solutions Group (Esg) From Dover Corporation
Sep 11, 2024 5:04 AM

Sept 10 (Reuters) - Terex Corp ( TEX ):

* TEREX ANNOUNCES EXPIRATION OF THE WAITING PERIOD UNDER THE

HART-SCOTT-RODINO ACT FOR PROPOSED ACQUISITION OF ENVIRONMENTAL

SOLUTIONS GROUP (ESG) FROM DOVER CORPORATION

* TEREX CORP ( TEX ) - EXPECTS ESG ACQUISITION TO CLOSE LATER THIS

YEAR

Source text for Eikon:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pan Global Says Intercepts Further Higher-Grade Gold and Copper Mineralization in Spain
Pan Global Says Intercepts Further Higher-Grade Gold and Copper Mineralization in Spain
Jun 18, 2025
08:10 AM EDT, 06/18/2025 (MT Newswires) -- Pan Global Resources ( PGZFF ) on Wednesday said new assay results for drillholes PVD03 and PVD04 completed in the maiden drill campaign at its 100%-owned Carmenes project located in northern Spain, expand the breccia-hosted gold zone to the east and north of the mine workings, and mineralization remains wide open. Higher-grade intervals...
Biomea Says Preclinical Results Show 'Robust' Weight Loss From Investigational Drug
Biomea Says Preclinical Results Show 'Robust' Weight Loss From Investigational Drug
Jun 18, 2025
08:12 AM EDT, 06/18/2025 (MT Newswires) -- Biomea Fusion ( BMEA ) said Wednesday that preclinical data for its investigational weight loss drug, BMF-650, showed robust weight loss and appetite suppression. The study, conducted with monkeys, showed 12% to 15% body weight reductions over 28 days, the company said. BMF-650 was well-tolerated, the company said, adding that plans to file...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Biogen Launches Phase 3 Pediatric Trial of Omaveloxolone for Friedreich Ataxia Treatment
Biogen Launches Phase 3 Pediatric Trial of Omaveloxolone for Friedreich Ataxia Treatment
Jun 18, 2025
08:12 AM EDT, 06/18/2025 (MT Newswires) -- Biogen (BIIB) said Wednesday it has begun dosing participants in a phase 3 trial to assess omaveloxolone for treating Friedreich ataxia, a rare neurodegenerative disorder, in children aged between 2 and 16 years. The study will assess the efficacy and safety of omaveloxolone in both ambulatory and non-ambulatory children, with participants randomized to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved